Publications

You are currently filtering by: Rare Disease

2017 • Progress in Neurobiology 152:149-165. PMID: 26854064.

Bakker AC, La Rosa S, Sherman LS, Knight P, Lee H, Pancza P, Nievo M

Full Article
2017 • Scientific Reports 7(1):17231. PMID: 29222447.

Bogdani M, Blackman SM, Ridaura C, Bellocq JP, Powers AC, Aguilar-Bryan L

Full Article
2017 • Molecular Cancer Research 15(10):1318-1330. PMID: 28710231.

Li C, Liu X, Liu Y, Zhang E, Medepalli K, Masuda K, Li N, Wikenheiser-Brokamp KA, Osterburg A, Borchers MT, Kopras EJ, Plas DR, Sun J, Franz DN, Capal JK, Mays M, Sun Y, Kwiatkowski DJ, Alayev A, Holz MK, Krueger DA, Siroky BJ, Yu JJ

Full Article
2017 • Modern Pathology 30(9):1223-1233. PMID: 28643793.

Murphy SJ, Terra SB, Harris FR, Nasir A, Voss JS, Smadbeck JB, Johnson SH, Serla V, Ryu JH, Yi ES, Kipp BR, Vasmatzis G, Carmona EM

Full Article
2017 • The Journal of Biological Chemistry 292(50):20528-20543. PMID: 28972182.

Stepanova V, Dergilev KV, Holman KR, Parfyonova YV, Tsokolaeva ZI, Teter M, Atochina-Vasserman EN, Volgina A, Zaitsev SV, Lewis SP, Zabozlaev FG, Obraztsova K, Krymskaya VP, Cines DB

Full Article
2017 • Oncotarget 8(22):36628-36638. PMID: 28410230.

Li X, Liu X, Zhang L, Li C, Zhang E, Ma W, Fan Q, Yu JJ

Full Article
2017 • The American Journal of Pathology 187(8):1750-1762. PMID: 28623674.

Dongre A, Clements D, Fisher AJ, Johnson SR

Full Article
2017 • Nature Communications 8(1):1848. PMID: 29184052.

Cho JH, Patel B, Bonala S, Manne S, Zhou Y, Vadrevu SK, Patel J, Peronaci M, Ghouse S, Henske EP, Roegiers F, Giannikou K, Kwiatkowski DJ, Mansouri H, Markiewski MM, White B, Karbowniczek M

Full Article
2017 • Annals of Cardiothoracic Surgery 6(6):610-624. PMID: 29270373.

Sulejmani F, Pokutta-Paskaleva A, Ziganshin B, Leshnower B, Iannucci G, Elefteriades J, Sun W

Full Article
2016 • Pulmonary Pharmacology & Therapeutics 36: 22-30. PMID: 26656789.
Effect of CFTR modifiers on arylsulfatase B activity in cystic fibrosis, normal human bronchial epithelial cells.

Bhattacharyyaa S, Fefermana L, Tobacman JK

1 2 3 4 5

NDRI is a Not-For-Profit (501c3) Corporation.